The continued partnership will support SingHealth in streamlining its clinical workflows to enhance care coordination SINGAPORE - Media OutReach - 20 July 2022 - Altera Digital.
E-Mail
IMAGE: Quantitative MR images of the liver from six patients presenting with liver cancer produced by Perspectum s LiverMultiScan which will be used in a new study led by National Cancer Centre. view more
Credit: Image credit: Mole DJ et al. Plos One. 2020;15(12):e0238568
Only 20% of primary liver cancer or hepatocellular carcinoma (HCC) are diagnosed at an early stage, which makes early detection an urgent, unmet healthcare need.
Study aims to develop more accurate diagnostics for early HCC, an AI algorithm to predict an individual s risk of developing HCC, and discover novel molecular targets to prevent the development of HCC.
E-Mail
Lung cancer continues to be the leading cause of cancer death in Singapore and the world.
The World Conference on Lung Cancer, the largest international gathering of clinicians, researchers and scientists in the field of lung cancer - with more than 6,000 participants - was held from 28 January to 31 January 2021 as a worldwide virtual event hosted by Singapore.
A group of Singapore clinicians and scientists presented new data to enhance understanding and treatment of lung cancer in the Asian population at the conference.
SINGAPORE, 1 FEBRUARY 2021 - Clinicians and scientists from Singapore shared exciting new data on lung cancer treatment in the Asian population at the World Conference on Lung Cancer Singapore, last week. Lung cancer develops very differently in Western and Asian populations, which makes understanding the disease from an Asian perspective a research priority for Singapore and the region.
Angiosarcomas are clinically aggressive tumours that are more prevalent in Asian populations
Study led by Singapore clinician-scientists has found a way to classify angiosarcomas into three subtypes, allowing for more targeted treatment, better outcomes for patients and the development of new therapies
Findings were published in
The Journal of Clinical Investigation in October this year
Singapore, 29 December 2020 - A new study led by clinician-scientists from the National Cancer Centre Singapore (NCCS), with collaborators from research institutions worldwide, has found that angiosarcomas have unique genomic and immune profiles which allow them to be classified into three different subtypes. With this new and improved classification system, patients can be treated using a personalised-medicine approach and it will encourage the development of novel treatments.